HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anna M Czarnecka Selected Research

Everolimus

6/2018Effect of Everolimus on Heterogenous Renal Cancer Cells Populations Including Renal Cancer Stem Cells.
1/2017Long-term response to sunitinib: everolimus treatment in metastatic clear cell renal cell carcinoma.
1/2015Future perspectives for mTOR inhibitors in renal cell cancer treatment.
12/2014Mammalian Target of Rapamycin Inhibitors Resistance Mechanisms in Clear Cell Renal Cell Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anna M Czarnecka Research Topics

Disease

52Neoplasms (Cancer)
03/2024 - 01/2006
33Renal Cell Carcinoma (Grawitz Tumor)
01/2021 - 09/2014
20Melanoma (Melanoma, Malignant)
05/2024 - 10/2018
12Kidney Neoplasms (Kidney Cancer)
09/2019 - 02/2014
11Sarcoma (Soft Tissue Sarcoma)
04/2024 - 01/2020
9Carcinogenesis
02/2023 - 01/2006
7Brain Neoplasms (Brain Tumor)
03/2023 - 09/2014
6Neoplasm Metastasis (Metastasis)
07/2023 - 11/2015
6Breast Neoplasms (Breast Cancer)
03/2017 - 04/2009
4Disease Progression
05/2024 - 01/2008
3Osteosarcoma (Osteogenic Sarcoma)
08/2023 - 07/2020
3Hypoxia (Hypoxemia)
01/2017 - 03/2016
2Chondrosarcoma
03/2024 - 05/2021
2Uveal melanoma
02/2024 - 06/2022
2Perivascular Epithelioid Cell Neoplasms
01/2023 - 08/2021
2Neurofibrosarcoma (MPNST)
12/2020 - 09/2020
2Hypertension (High Blood Pressure)
11/2017 - 09/2014
2Pancreatic Neoplasms (Pancreatic Cancer)
12/2016 - 02/2016
2Necrosis
09/2014 - 09/2013
2Adenocarcinoma
10/2009 - 08/2008
1Lymphatic Metastasis
01/2024
1Myocarditis (Carditis)
09/2022
1Stomach Neoplasms (Stomach Cancer)
12/2021
1Merkel Cell Carcinoma
06/2021
1Chromosome Aberrations (Chromosome Abnormalities)
03/2021
1Rhabdomyosarcoma
02/2021
1Synovial Sarcoma (Synovioma)
09/2020
1Hemangiosarcoma (Angiosarcoma)
06/2020
1Cardiotoxicity
01/2020
1Leiomyosarcoma
01/2020
1Neoplasm Micrometastasis
11/2019
1Metabolic Diseases (Metabolic Disease)
09/2019
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
09/2019

Drug/Important Bio-Agent (IBA)

11Mitochondrial DNA (mtDNA)IBA
02/2011 - 01/2006
9Biomarkers (Surrogate Marker)IBA
04/2024 - 09/2014
9Tyrosine Kinase InhibitorsIBA
01/2021 - 09/2014
8Sunitinib (Sutent)FDA Link
09/2019 - 09/2014
7Proteins (Proteins, Gene)FDA Link
02/2024 - 01/2008
5Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2023 - 10/2018
5Sorafenib (BAY 43-9006)FDA Link
07/2020 - 01/2015
4L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
04/2022 - 05/2018
4TOR Serine-Threonine KinasesIBA
03/2021 - 12/2014
4pazopanibFDA Link
07/2020 - 01/2015
4EverolimusFDA Link
06/2018 - 12/2014
3MicroRNAs (MicroRNA)IBA
03/2024 - 07/2020
3MTOR InhibitorsIBA
01/2023 - 12/2014
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 01/2020
3DNA (Deoxyribonucleic Acid)IBA
04/2015 - 07/2006
2RNA (Ribonucleic Acid)IBA
02/2024 - 01/2016
2pembrolizumabIBA
07/2023 - 06/2022
2Immune Checkpoint InhibitorsIBA
09/2022 - 01/2021
2NivolumabIBA
06/2022 - 04/2020
2Reactive Oxygen Species (Oxygen Radicals)IBA
12/2021 - 12/2016
2AntibodiesIBA
01/2021 - 10/2020
2IfosfamideFDA LinkGeneric
01/2021 - 01/2020
2IpilimumabIBA
09/2020 - 04/2020
2GemcitabineFDA Link
01/2020 - 02/2016
2Laminin (Merosin)IBA
11/2019 - 02/2019
2Insulin (Novolin)FDA Link
09/2019 - 12/2016
2Culture MediaIBA
02/2019 - 04/2018
2EndocannabinoidsIBA
05/2018 - 01/2016
2Hormones (Hormone)IBA
04/2018 - 06/2016
2Oxygen (Dioxygen)IBA
01/2017 - 03/2016
2Insulin-Like Growth Factor I (IGF-1)IBA
12/2016 - 01/2016
2Calcitriol Receptors (Calcitriol Receptor)IBA
06/2016 - 02/2014
2Phosphotransferases (Kinase)IBA
01/2016 - 01/2015
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2015 - 09/2013
2NADH DehydrogenaseIBA
06/2010 - 02/2010
2Mitochondrial Proteins (Mitochondrial Protein)IBA
04/2009 - 07/2006
2Molecular Chaperones (Chaperone, Molecular)IBA
04/2007 - 07/2006
1Interferon-gamma (Interferon, gamma)IBA
03/2024
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
02/2024
1tebentafuspIBA
02/2024
1VemurafenibIBA
01/2023
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
06/2022
1Fluorescein (Funduscein)FDA LinkGeneric
06/2022
1Sirolimus (Rapamycin)FDA Link
08/2021
1Cyclin-Dependent Kinase Inhibitor p16IBA
03/2021
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
03/2021
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
03/2021
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
03/2021
1EndoglinIBA
02/2021
1MitogensIBA
10/2020
1lactate dehydrogenase 2IBA
09/2020
1cabozantinibIBA
07/2020
1IntegrasesIBA
07/2020
1Mitogen-Activated Protein KinasesIBA
06/2020
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
06/2020
1Nucleosomes (Nucleosome)IBA
06/2020
1Dacarbazine (DIC)FDA LinkGeneric
01/2020
1AnthracyclinesIBA
01/2020
1Imatinib Mesylate (Gleevec)FDA Link
09/2019
1Insulin-Like PeptidesIBA
09/2019

Therapy/Procedure

46Therapeutics
05/2024 - 04/2007
17Immunotherapy
05/2024 - 01/2017
8Radiotherapy
09/2023 - 09/2015
8Drug Therapy (Chemotherapy)
09/2023 - 09/2015
3Neoadjuvant Therapy
03/2024 - 12/2021
2Lymph Node Excision (Lymph Node Dissection)
01/2024 - 05/2023
1Combined Modality Therapy
10/2020